Technical Track
The CRN 2025 Technical Track will focus on supporting the development of novel, sustainable tools to accelerate validation and therapeutic R&D for emerging targets identified through ASAP discoveries.
Areas of Focus
Tools for emerging targets could include:
- Generation of preclinical models to support in vivo or in vitro assessments of targets of interest
- Generation of detection reagents such as antibodies, nanobodies, or probes to support improved measurement or visualization of the target or target activity
- Generation of modulation agents such as viral vectors, compounds, or antisense oligonucleotides to understand directionality of therapeutic benefit for PD
Check back here for updates on emerging targets of interest!
Requirements
Projects
ASAP will support core teams that can generate specific tool types for multiple targets that can be made available to the broader research community through easy access mechanisms.
Core Team Composition
The makeup of the team should include 2-3 Lead Principal Investigators with expertise in the following:
- Expertise in PD/target biology of interest
- Expertise in tool development and characterization (dependent on tool type proposed)
- Representation from academic core/company (CRO) to design, generate, and distribute the proposed tool that can demonstrate global distribution capabilities to non-profit and for-profit customers through click-to-order e-commerce system
- Project Manager to monitor tool status, liaise with other funded teams, and register tools
Open Science Policy
ASAP is built on strong open science policies. Awardees and team members agree to follow all ASAP open science policies.
Call Details
- ASAP will open the call for Letters of Intent (LOIs) in early 2025
- LOI submissions will be due in mid 2025
- ASAP will announce funding decisions in early 2026
- Awarded teams will receive funding of up to $2M per year for three years
CRN 2025 Funding Updates
Sign up to receive updates about ASAP’s two open competitive funding opportunities.
